Advertisement
Screener

AKEBIA THERAPEUTICS, INC. (AKBA) Lessor, Operating Lease, Payments to be Received

2.8 / 5 stars · 68/120 Roast Me

AKEBIA THERAPEUTICS, INC. Lessor, Operating Lease, Payments to be Received

AKEBIA THERAPEUTICS, INC. (AKBA) had Lessor, Operating Lease, Payments to be Received of $307.00 thousand as of 2022-12-31, per its 10-K/A filed 2023-08-28.

Discontinued › Notes › Leases › Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity

us-gaap:LessorOperatingLeasePaymentsToBeReceived · last filed 2023-08-28

  • 2022-12-31: Lessor, Operating Lease, Payments to be Received $307.00K.
  • 2022-09-30: Lessor, Operating Lease, Payments to be Received $768.00K.
  • 2022-06-30: Lessor, Operating Lease, Payments to be Received $1.22M.
  • 2022-03-31: Lessor, Operating Lease, Payments to be Received $1.68M.
Period endLessor, Operating Lease, Payments to be Received
2022-12-31$307.00K
10-K/A · filed 2023-08-28
2022-09-30$768.00K
10-Q · filed 2022-11-03
2022-06-30$1.22M
10-Q · filed 2022-08-04
2022-03-31$1.68M
10-Q · filed 2022-05-09
2021-12-31$2.13M
10-K · filed 2022-03-01
2021-09-30$2.58M
10-Q · filed 2021-11-04
2021-06-30$3.03M
10-Q · filed 2021-08-05
2021-03-31$3.48M
10-Q · filed 2021-05-10
2020-12-31$3.93M
10-K · filed 2021-02-25
2020-09-30$4.38M
10-Q · filed 2020-11-05
2020-06-30$4.82M
10-Q · filed 2020-08-10
2020-03-31$5.26M
10-Q · filed 2020-05-05
2019-12-31$5.70M
10-K · filed 2020-03-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
MACROGENICS INC (MGNX)United States$0.242B-20.11
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33